Approval for a change of the trade name of your device from supartz to supartz fx. the device, as modified, will be marketed under the trade name supartz fx and is indicated for the treatment of pain in osteoarthritis (oa) of the knee in patients who have failed to respond adequately to conservative, non-pharmacologic therapy and simple analgesics, e. g., acetaminophen.